Total Receivables - vTv Therapeutics Inc (NASDAQ:VTVT) - Alpha Spread

vTv Therapeutics Inc
NASDAQ:VTVT

Watchlist Manager
vTv Therapeutics Inc Logo
vTv Therapeutics Inc
NASDAQ:VTVT
Watchlist
Price: 14.93 USD 6.41% Market Closed
Market Cap: 36.3m USD
Have any thoughts about
vTv Therapeutics Inc?
Write Note

vTv Therapeutics Inc
Total Receivables

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

vTv Therapeutics Inc
Total Receivables Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Total Receivables Analysis
Latest Figures & CAGR of Competitors

Company Total Receivables CAGR 3Y CAGR 5Y CAGR 10Y
vTv Therapeutics Inc
NASDAQ:VTVT
Total Receivables
$306k
CAGR 3-Years
N/A
CAGR 5-Years
-30%
CAGR 10-Years
N/A
Abbvie Inc
NYSE:ABBV
Total Receivables
$11.7B
CAGR 3-Years
6%
CAGR 5-Years
16%
CAGR 10-Years
12%
Gilead Sciences Inc
NASDAQ:GILD
Total Receivables
$4.7B
CAGR 3-Years
4%
CAGR 5-Years
7%
CAGR 10-Years
3%
Amgen Inc
NASDAQ:AMGN
Total Receivables
$6.9B
CAGR 3-Years
16%
CAGR 5-Years
13%
CAGR 10-Years
10%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Total Receivables
$1.7B
CAGR 3-Years
21%
CAGR 5-Years
29%
CAGR 10-Years
35%
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Total Receivables
$5.7B
CAGR 3-Years
-7%
CAGR 5-Years
18%
CAGR 10-Years
20%

See Also

What is vTv Therapeutics Inc's Total Receivables?
Total Receivables
306k USD

Based on the financial report for Jun 30, 2024, vTv Therapeutics Inc's Total Receivables amounts to 306k USD.

What is vTv Therapeutics Inc's Total Receivables growth rate?
Total Receivables CAGR 5Y
-30%

Back to Top